Clinical Trials in Salt Lake City

Showing 10041-10060 of 16,694 trials

COMPLETEDPhase 1< 1 mile

A Study to Investigate the Effects of Cytochrome P450 1A2 Induction by Ritonavir on BMS-986165 Drug Levels and Effects in Healthy Participants

NCT04055506

The Study of Cytochrome P450 1A2 Induction by Ritonavir on the drug effects of BMS-986165 in Healthy Participants

Healthy Participants

Bristol-Myers Squibb16 participantsStarted Aug 2019

Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

NCT02441946

The purpose of this study is to evaluate the biological effects of abemaciclib in combination with anastrozole and compare those to the effects of abemaciclib alone and anastrozole alone in the tumors of postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 (HER2) negative breast cancer.

Breast CancerHormone Receptor Positive TumorEarly-Stage Breast Carcinoma

Eli Lilly and Company224 participantsStarted Aug 2015

Bakersfield, California, United States • La Jolla, California, United States • Los Angeles, California, United States +63 more locations

A Study to Investigate the Effects of Cytochrome P450 1A2 Induction by Ritonavir on BMS-986165 Drug Levels and Effects in Healthy Participants

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

Find Trials by Condition in Salt Lake City

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)

A Gene Therapy Study for Hemophilia B

GSK2982772 Study in Subjects With Ulcerative Colitis

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections